Upregulation of OLR1 and IL17A genes and their association with blood glucose and lipid levels in femoropopliteal artery disease

Arslan,Caner; Bayoglu,Burcu; Tel,Cigdem; Cengiz,Mujgan; Dirican,Ahmet; Besirli,Kazim

doi:10.3892/etm.2017.4081

Upregulation of OLR1 and IL17A genes and their association with blood glucose and lipid levels in femoropopliteal artery disease

Authors:
- Caner Arslan
- Burcu Bayoglu
- Cigdem Tel
- Mujgan Cengiz
- Ahmet Dirican
- Kazim Besirli
View Affiliations

Affiliations: Department of Cardiovascular Surgery, Cerrahpasa Medical Faculty, Istanbul University, Istanbul 34098, Turkey, Department of Medical Biology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul 34098, Turkey, Department of Biostatistics and Medical Informatics, Istanbul Medical Faculty, Istanbul University, Istanbul 34093, Turkey
Published online on: January 24, 2017 https://doi.org/10.3892/etm.2017.4081
Pages: 1160-1168

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oxidized low-density lipoprotein receptor 1 (OLR1) and interleukin 17A (IL17A) have pro-inflammatory roles in the development of cardiovascular disorders. The present study evaluated the association of OLR1 and IL17A and their polymorphisms with the development of femoropopliteal (FP) artery disease. The mRNA expression of OLR1 and IL17A in peripheral blood mononuclear cells as well as the frequency of OLR1 rs11053646 and IL17A rs8193037 and rs3819025 polymorphisms were assessed by polymerase chain reaction in 70 patients with FP artery disease and 80 age‑matched disease‑free controls. Furthermore, the levels of plasma cytokines were assessed by multiplex immunoassay. OLR1 and IL17A mRNA expression was significantly higher in patients with FP artery disease compared with that in controls (P<0.001). No significant difference was observed in the genotypic frequencies of OLR1 rs11053646 (P=0.87) or in IL17A rs8193037 and rs3819025 (P=0.80 and 0.92, respectively) polymorphisms between patients with FP artery disease and controls. Plasma IL4, ‑6, ‑10, ‑22, ‑31 and ‑33 as well as soluble cluster of differentiation 40 ligand and tumor necrosis factor‑α levels were significantly increased among FP artery disease patients compared with controls (P<0.05). Furthermore, OLR1 expression was positively correlated with triglyceride (r=0.463, P<0.001), low‑density lipoprotein cholesterol (r=0.507, P<0.001) and total cholesterol levels (r=0.357, P=0.006) in patients with FP artery disease. To the best of our knowledge, the present study was the first to identify an association between OLR1 and IL17A genes and FP artery disease. OLR1 and IL17A mRNA transcripts may be associated with blood lipid parameters and with the development of FP artery disease.

View Figures

View References

1	Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group; Bell K, Caporusso J, Durand-Zaleski I, et al: Inter-Society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 33:(Suppl 1). S1–S75. 2007. View Article : Google Scholar : PubMed/NCBI
2	Hernando FJ Serrano and Martín Conejero A: Peripheral artery disease: Pathophysiology, diagnosis and treatment. Rev Esp Cardiol. 60:969–982. 2007.(In Spanish). PubMed/NCBI
3	Mahameed AA: Peripheral arterial disease. http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/peripheral-arterial-disease/Accessed. January 11–2009.
4	Kullo IJ and Leeper NJ: The genetic basis of peripheral arterial disease: Current knowledge, challenges, and future directions. Circ Res. 116:1551–1560. 2015. View Article : Google Scholar : PubMed/NCBI
5	Chen XP and Du GH: Lectin-like oxidized low-density lipoprotein receptor-1: Protein, ligands, expression and pathophysiological significance. Chin Med J (Engl). 120:421–426. 2007.PubMed/NCBI
6	Arjuman A and Chandra NC: Effect of IL-10 on LOX-1 expression, signaling and functional activity: An atheroprotective response. Diab Vasc Dis Res. 10:442–451. 2013. View Article : Google Scholar : PubMed/NCBI
7	Tesmer LA, Lundy SK, Sarkar S and Fox DA: Th17 cells in human disease. Immunol Rev. 223:87–113. 2008. View Article : Google Scholar : PubMed/NCBI
8	Taleb S, Tedgui A and Mallat Z: Adaptive T cell immune responses and atherogenesis. Curr Opin Pharmacol. 10:197–202. 2010. View Article : Google Scholar : PubMed/NCBI
9	Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ and Harrison DG: Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension. 55:500–507. 2010. View Article : Google Scholar : PubMed/NCBI
10	Zhang X, Pei F, Zhang M, Yan C, Huang M, Wang T and Han Y: Interleukin-17A gene variants and risk of coronary artery disease: A large angiography-based study. Clin Chim Acta. 412:327–331. 2011. View Article : Google Scholar : PubMed/NCBI
11	Mai J, Nanayakkara G, Lopez-Pastrana J, Li X, Li YF, Wang X, Song A, Virtue A, Shao Y, Shan H, et al: Interleukin-17A promotes aortic endothelial cell activation via transcriptionally and post-translationally activating p38 mitogen-activated protein kinase (MAPK) pathway. J Biol Chem. 291:4939–4954. 2016. View Article : Google Scholar : PubMed/NCBI
12	Biocca S, Falconi M, Filesi I, Baldini F, Vecchione L, Mango R, Romeo F, Federici G, Desideri A and Novelli G: Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity. PLoS One. 4:e46482009. View Article : Google Scholar : PubMed/NCBI
13	Tatsuguchi M, Furutani M, Hinagata J, Tanaka T, Furutani Y, Imamura S, Kawana M, Masaki T, Kasanuki H, Sawamura T and Matsuoka R: Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun. 303:247–250. 2003. View Article : Google Scholar : PubMed/NCBI
14	Hou XW, Wang LF, Wang N, Pang D, Hui B, Zhou YL and He X: The G501C polymorphism of oxidized LDL receptor gene [OLR-1] is associated with susceptibility and serum C-reactive protein concentration in Chinese essential hypertensives. Clin Chim Acta. 388:200–203. 2008. View Article : Google Scholar : PubMed/NCBI
15	Hattori H, Sonoda A, Sato H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K and Suzuki N: G501C polymorphism of oxidized LDL receptor gene (OLR1) and ischemic stroke. Brain Res. 1121:246–249. 2006. View Article : Google Scholar : PubMed/NCBI
16	Zhang J, Yin C, Zhang Y, Zhao L, Fu H and Feng J: The role of OLR1 polymorphisms in determining the risk and prognosis of ischemic stroke in a Chinese population. NeuroRehabilitation. 32:391–396. 2013.PubMed/NCBI
17	Liu X, Zhu RX, Li L and He ZY: Association of LOX-1 gene polymorphisms with cerebral infarction in northern Chinese Han population. Lipids Health Dis. 13:552014. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Libby P, Ridker PM and Maseri A: Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002. View Article : Google Scholar : PubMed/NCBI
20	Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH and Ponnambalam S: The lectin-like oxidized low-density-lipoprotein receptor: A pro-inflammatory factor in vascular disease. Biochem J. 409:349–355. 2008. View Article : Google Scholar : PubMed/NCBI
21	Liuzzo G, Trotta F and Pedicino D: Interleukin-17 in atherosclerosis and cardiovascular disease: The good, the bad, and the unknown. Eur Heart J. 34:556–559. 2013. View Article : Google Scholar : PubMed/NCBI
22	Lim H, Kim YU, Sun H, Lee JH, Reynolds JM, Hanabuchi S, Wu H, Teng BB and Chung Y: Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity. 40:153–165. 2014. View Article : Google Scholar : PubMed/NCBI
23	Goyal T, Mitra S, Khaidakov M, Wang X, Singla S, Ding Z, Liu S and Mehta JL: Current concepts of the role of oxidized LDL receptors in atherosclerosis. Curr Atheroscler Rep. 2012.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
24	Hansson GK and Hermansson A: The immune system in atherosclerosis. Nat Immunol. 12:204–212. 2011. View Article : Google Scholar : PubMed/NCBI
25	Gao S and Geng YJ: LOX-1: A male hormone-regulated scavenger receptor for atherosclerosis. Vascul Pharmacol. 59:138–143. 2013. View Article : Google Scholar : PubMed/NCBI
26	Fukui M, Tanaka M, Senmaru T, Nakanishi M, Mukai J, Ohki M, Asano M, Yamazaki M, Hasegawa G and Nakamura N: LOX-1 is a novel marker for peripheral artery disease in patients with type 2 diabetes. Metabolism. 62:935–938. 2013. View Article : Google Scholar : PubMed/NCBI
27	Ding Z, Mizeracki AM, Hu C and Mehta JL: LOX-1 deletion and macrophage trafficking in atherosclerosis. Biochem Biophys Res Commun. 440:210–214. 2013. View Article : Google Scholar : PubMed/NCBI
28	Au A, Griffiths LR, Cheng KK, Wee Kooi C, Irene L and Wei L Keat: The influence of OLR1 and PCSK9 gene polymorphisms on ischemic stroke: Evidence from a meta-analysis. Sci Rep. 5:182242015. View Article : Google Scholar : PubMed/NCBI
29	Potekhina AV, Pylaeva E, Provatorov S, Ruleva N, Masenko V, Noeva E, Krasnikova T and Arefieva T: Treg/Th17 balance in stable CAD patients with different stages of coronary atherosclerosis. Atherosclerosis. 238:17–21. 2015. View Article : Google Scholar : PubMed/NCBI
30	Madhur MS, Funt SA, Li L, Vinh A, Chen W, Lob HE, Iwakura Y, Blinder Y, Rahman A, Quyyumi AA and Harrison DG: Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol. 31:1565–1572. 2011. View Article : Google Scholar : PubMed/NCBI
31	Ge S, Hertel B, Koltsova EK, Sörensen-Zender I, Kielstein JT, Ley K, Haller H and von Vietinghoff S: Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A. Circ Res. 113:965–974. 2013. View Article : Google Scholar : PubMed/NCBI
32	Rao LN, Ponnusamy T, Philip S, Mukhopadhyay R, Kakkar VV and Mundkur L: Hypercholesterolemia induced immune response and inflammation on progression of atherosclerosis in Apob(tm2Sgy) Ldlr(tm1Her)/J mice. Lipids. 50:785–797. 2015. View Article : Google Scholar : PubMed/NCBI
33	Vargas-Alarcón G, Angeles-Martínez J, Villarreal-Molina T, Alvarez-León E, Posadas-Sánchez R, Cardoso-Saldaña G, Ramírez-Bello J, Pérez-Hernández N, Juárez-Rojas JG, Rodríguez-Pérez JM, et al: Interleukin-17A gene haplotypes are associated with risk of premature coronary artery disease in Mexican patients from the Genetics of Atherosclerotic Disease (GEA) study. PLoS One. 10:e01149432015. View Article : Google Scholar : PubMed/NCBI